cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Prothena Corporation Plc
3 own
6 watching
Current Price
$57.12
$1.27
(2.27%)
logo-prta
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,735.23M
52-Week High
52-Week High
66.47
52-Week Low
52-Week Low
21.06
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
43.4636
iconMarket Capitalization2,735.23M
icon52-Week High66.47
icon52-Week Low21.06
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio43.4636
What does the Prothena Corporation Plc do?
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. It is developing antibody-based product candidates that include NEOD001, a monoclonal antibody that is in Phase III and Phase IIb clinical trials for the treatment of AL amyloidosis; PRX002 that has completed Phase Ib clinical trial for treating Parkinson's disease and other related synucleinopathies; PRX003, a monoclonal antibody that is in Phase Ib for the treatment of psoriasis and other inflammatory diseases; and PRX004, a monoclonal antibody that is under preclinical development. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein. Prothena Corporation plc was incorporated in 2012 and is headquartered in Dun Laoghaire, Ireland.
Read More
How much money does Prothena Corporation Plc make?
News & Events about Prothena Corporation Plc.
Business Wire
1month ago
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it priced an underwritten public offering of 3,250,000 of its ordinary shares at a price to the...
Business Wire
1month ago
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today presented data from the completed phase 3 VITAL study demonstrating that in a post hoc analysis of patients with...
Business Wire
2 months ago
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will present survival data from the phase 3 VITAL study at an oral presentation at the...
Zolmax
3 months ago
Prothena Co. plc (NASDAQ:PRTA Get Rating) CEO Gene G. Kinney sold 16,412 shares of the stock in a transaction that occurred on Wednesday, September 28th. The shares were sold at an average price of $53.38, for a total transaction of $876,072.56. Following the completion of the transaction, the chief...
PR Newswire
4 months ago
Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies? Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies? PR Newswire NEW YORK, Sept. 28, 2022 NEW YORK...
Frequently Asked Questions
Frequently Asked Questions
What is Prothena Corporation Plc share price today?
plus_minus_icon
Can Indians buy Prothena Corporation Plc shares?
plus_minus_icon
How can I buy Prothena Corporation Plc shares from India?
plus_minus_icon
Can Fractional shares of Prothena Corporation Plc be purchased?
plus_minus_icon
What are the documents required to start investing in Prothena Corporation Plc stocks?
plus_minus_icon
What is today’s traded volume of Prothena Corporation Plc?
plus_minus_icon
What is today’s market capitalisation of Prothena Corporation Plc?
plus_minus_icon
What is the 52-Week High and Low Range of Prothena Corporation Plc?
plus_minus_icon
What percentage is Prothena Corporation Plc down from its 52-Week High?
plus_minus_icon
What percentage is Prothena Corporation Plc up from its 52-Week Low?
plus_minus_icon
Current Price
$57.12
$1.27
(2.27%)
logo-prta
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00